Is Sotera Health Co (SHC) overvalued? · P/E 38, rev $1.16B
Sotera Health Co (SHC) is a diagnostics & research company listed on NASDAQ.
This page asks whether Sotera Health Co (SHC) looks expensive on cached numbers — not a short thesis.
Latest reported SHC revenue for 2025-12-31 was $1.16B. Net income was $77.9M. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. SHC currently screens at market cap $4.41B and trailing P/E 37.7.
SHC currently screens at market cap $4.41B and trailing P/E 37.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SHC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SHC stock page for the full model, not this heading.
Not investment advice.